J, B., V, S., A, R., ML, J., M, G., A, P., . . . F, B. (2021). Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy. Nature communications, 12(1), 5343. https://doi.org/10.1038/s41467-021-25697-y
Chicago Style (17th ed.) CitationJ, Bertolin, et al. "Treatment of Skeletal and Non-skeletal Alterations of Mucopolysaccharidosis Type IVA by AAV-mediated Gene Therapy." Nature Communications 12, no. 1 (2021): 5343. https://doi.org/10.1038/s41467-021-25697-y.
MLA (9th ed.) CitationJ, Bertolin, et al. "Treatment of Skeletal and Non-skeletal Alterations of Mucopolysaccharidosis Type IVA by AAV-mediated Gene Therapy." Nature Communications, vol. 12, no. 1, 2021, p. 5343, https://doi.org/10.1038/s41467-021-25697-y.